There are scientific achievements that expand human freedom, alleviate suffering, and improve civilization. Then there are achievements that force us to ask whether possessing the ability to do something is sufficient justification for doing it. The emerging convergence of artificial intelligence and virology belongs squarely in the latter category.
Artificial intelligence can already help researchers analyze enormous biological datasets, identify proteins, predict molecular structures, and accelerate drug development. Those capabilities could prove enormously beneficial. But the same computational power that helps scientists understand pathogens can potentially make it easier to design, modify, or optimize them.
That should concern everyone.
For generations, scientific culture has operated on an assumption that knowledge itself is inherently beneficial and that responsible researchers can manage the dangers accompanying discovery. History suggests greater humility is warranted. Nuclear physics gave humanity both nuclear power and thermonuclear weapons. Chemistry produced medicines and chemical warfare agents. Biotechnology promises revolutionary treatments while simultaneously creating capabilities that could be catastrophically misused.
AI dramatically accelerates this problem because it lowers barriers between specialized knowledge and practical application.
A dangerous biological experiment once might have required years of specialized education, extensive laboratory experience, and access to experts capable of solving difficult technical problems. Increasingly sophisticated AI systems could compress portions of that expertise into software capable of assisting researchers with complex biological questions.
The ethical question therefore extends beyond what scientists intend to accomplish. We must consider what capabilities their research creates for everyone else.
Consider the consequences if researchers develop an AI system capable of suggesting modifications that make a virus more transmissible, more resistant to existing treatments, or better able to evade immune defenses. Even if the original researchers are studying those characteristics for defensive purposes, the knowledge does not necessarily remain confined to them.
Information escapes.
Databases are hacked. Research papers circulate. Employees make mistakes. Governments conduct espionage. Algorithms are copied. Institutions change leadership. Scientists move between laboratories.
Once dangerous biological knowledge becomes reproducible digital information, controlling it becomes extraordinarily difficult.
This is where the traditional scientific argument for openness collides with national security. Scientists understandably favor publishing results so experiments can be replicated and knowledge can advance. That philosophy works remarkably well when researchers are developing better batteries or studying distant galaxies. It becomes considerably more complicated when published information could theoretically help someone engineer a dangerous pathogen.
The conservative principle of prudence offers an important guide here: institutions should not gamble with catastrophic consequences simply because technological progress makes the gamble possible.
This does not mean abandoning biotechnology or artificial intelligence. Both could produce extraordinary medical advances. AI might help researchers identify emerging pathogens faster, design vaccines more rapidly, discover antivirals, and understand diseases that currently kill millions.
But beneficial applications do not eliminate dangerous ones.
The scientific community therefore cannot be allowed to police itself exclusively. Researchers have expertise, but expertise does not confer democratic authority. Decisions carrying potentially civilization-scale consequences deserve scrutiny from elected governments, national-security professionals, independent bioethicists, and the public.
That oversight must extend to funding.
Taxpayers deserve to know whether their money supports experiments involving potentially dangerous manipulation of pathogens, what safeguards govern those experiments, and which institutions are ultimately accountable when something goes wrong. Bureaucratic complexity cannot become a shield against responsibility.
International competition makes the problem even harder. The United States could impose stringent restrictions while hostile governments continue aggressive biological research. Unilateral scientific restraint may therefore create vulnerabilities rather than eliminate them.
That means America needs something more sophisticated than simply banning research. It needs strong biodefense capabilities combined with strict controls over experiments capable of producing unusually dangerous biological agents. High-risk AI-biological systems should receive security scrutiny comparable to other technologies with major national-security implications.
The threshold for proceeding should also become considerably higher as the potential consequences increase.
Researchers sometimes argue that dangerous pathogens must be studied so humanity can prepare for them. There is logic to that position. Yet creating or substantially enhancing a threat in order to understand a hypothetical future threat creates its own moral paradox. At some point, preparation can become creation.
Scientists should have to demonstrate not merely that an experiment might produce useful knowledge, but that the expected benefit clearly outweighs the possibility of catastrophic failure or misuse.
And some experiments may simply fail that test.
Human civilization has spent centuries learning that technological power must be accompanied by institutional restraint. AI-enabled biology may become one of the greatest tests of that lesson.
The danger is not that scientists are malicious. Most are not. The danger is that intelligent, well-intentioned people can become so captivated by what they are capable of discovering that they underestimate what others might eventually do with their discoveries.
Artificial intelligence is rapidly expanding the boundaries of biological possibility. Our ethical boundaries must advance just as quickly.
Because when the potential mistake is a computer crash, we can reboot the machine.
When the potential mistake is a virus, there may be no reset button.